IL12RB2 is involved in IL-35 control, which is important for atherosclerosis and inflammation [31] and has been shown to inhibit ischemia/hypoxia-induced angiogenesis, suggesting that this anti-inflammatory cytokine plays new roles at the recovery stage of angiogenesis [32]. This evidence concerns the gene IL12RB2 and atherosclerosis.